CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Top Upcoming Trends In Pharma Industry

Top Upcoming Trends In Pharma Industry

French Pharmaceutical Company Rigorously Audits Multiple Digital Validation Solutions Selects ValGenesis VLMS

French Pharmaceutical Company...

Data Science In R&D: It Is About Culture

Data Science In R&D: It Is About Culture

Three Steps To Succeed With Digital Transformation In Pharma?

Three Steps To Succeed With Digital...

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Partnering With A Cdmo For Successful...

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Leading Global Cdmo, Pci Has Further...

Encouraging Innovation in Healthcare in a COVID - 19 World

Encouraging Innovation in Healthcare...

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies...

Top Upcoming Trends In Pharma Industry

Top Upcoming Trends In Pharma Industry

French Pharmaceutical Company Rigorously Audits Multiple Digital Validation Solutions Selects ValGenesis VLMS

French Pharmaceutical Company...

Data Science In R&D: It Is About Culture

Data Science In R&D: It Is About Culture

Three Steps To Succeed With Digital Transformation In Pharma?

Three Steps To Succeed With Digital...

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Partnering With A Cdmo For Successful...

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Leading Global Cdmo, Pci Has Further...

Encouraging Innovation in Healthcare in a COVID - 19 World

Encouraging Innovation in Healthcare...

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies...

Arisglobal's Lifesphere Safety Bolsters Market Leading Position In Pharmacovigilance

Life Sciences Review Life Sciences Review | Friday, March 18, 2022
Tweet

Fremont, CA: The life sciences industry has always been driven by research and innovation, and more so now than ever, with breakthroughs in drug development, investments in accelerating drug launches, and opportunities in medical advancement.


ArisGlobal, the leading provider of life sciences software that automates core drug development functions with its end-to-end technology platform LifeSphere, has shown significant growth in the global adoption of its LifeSphere Safety platform bolstering its position as the most used drug safety software across the world. LifeSphere Safety, an innovative safety suite that has been in development for 30 years, processes the largest number of safety cases across a customer base that includes emerging biotechs, top 5 pharmaceutical companies, and key regulatory entities such as the FDA.


 


 


LifeSphere, which provides safety case management efficiency gains of up to 80 percent, is the preferred pharmacovigilance technology for 4 of the 5 largest biopharmas, with the largest global biopharma recently choosing LifeSphere Safety in late 2021.


"With the current and future steep rise of adverse events, pharmacovigilance has become an increasingly strategic area for life sciences organizations. Leveraging automation technology with a scalable architecture is a growing necessity for organizations to bring safer drugs to market, faster," stated Steve Nuckols, Chief Revenue Officer at ArisGlobal. "For many years, LifeSphere Safety has been on a growing adoption trajectory in the industry, including the world's top pharmaceutical companies. We're continuing with our momentum and investing more resources to accelerate our growth."


 


Weekly Brief

loading
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis
Data Science In R&D: It Is About Culture

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore, at Lonza
Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Chris Dobbs, CEng., MIET, Head of Technical Engineering, PCI Pharma Services
Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Encouraging Innovation in Healthcare in a COVID - 19 World

Duncan Turner, General Partner, SOSV, Managing Director, HAX
Encouraging Innovation in Healthcare in a COVID - 19 World
How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

Gil Carrasquinho, VP Head of Cell Therapy, Santen
Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Craig Herron, Managing Director, iSelect Fund

Addressing the Expanded Role of Patient Engagement in Clinical Research

Denis Curtin, PhD, Principal, eCOA & Patient Engagement, Signant Health
Addressing the Expanded Role of Patient Engagement in Clinical Research

The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery

Jason Hipp, Senior Director, Head of Pathology Data Science & Innovation, Translational, AstraZeneca
The Future of Imaging and the Role of the Pathology Data Scientist in Drug Discovery
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/arisglobal-s-lifesphere-safety-bolsters-market-leading-position-in-pharmacovigilance-nwid-748.html